A new decade of the 21st century is starting. We have experienced multiple shake-ups in the course of the last decade, the ‘teens-decade’—political ones and social ones, such as the climate crisis which affects us globally and might even influence the epidemiology of rheumatic diseases in the not too distant future. Hopefully the new decade will find solutions for some of the burning problems of the planet and its societies. In rheumatology, the first decade of this millennium brought novel therapies especially for rheumatoid arthritis (RA),1 2 changing the lives of millions of patients with RA around the world and making rheumatology one of the most successful medical specialties, attracting many young people to specialise in the field. The second decade brought several major therapeutic advances beyond tumour necrosis factor inhibitors especially for patients with psoriatic arthritis and axial spondyloarthritis3 4; the advent of biosimilars …

中文翻译：

---

来自编辑的问候 2020

21世纪新的十年即将开始。在过去的十年中，我们经历了多次变革——政治和社会变革，比如气候危机，它在全球范围内影响我们，甚至可能在不太远的时候影响风湿病的流行病学。遥远的未来。希望新的十年能够为地球及其社会的一些紧迫问题找到解决方案。在风湿病学领域，本世纪的第一个十年带来了特别是类风湿性关节炎 (RA) 的新疗法，1 2 改变了全世界数百万 RA 患者的生活，并使风湿病学成为最成功的医学专业之一，吸引了许多年轻人专攻该领域。第二个十年带来了除肿瘤坏死因子抑制剂以外的几项重大治疗进展，特别是对于银屑病关节炎和中轴性脊柱关节炎患者 3 4；生物仿制药的出现……